DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 – Investing News Network

DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018  Investing News Network

DBV Technologies (Euronext:DBV;Nasdaq:DBVT), a clinical-stage biopharmaceutical company, announced that an oral abstract evaluating differences in the.

Original published: 2018-12-12 17:45:08 Read the full Vienna News here


Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.